ZICX:OTO-Zicix Corporation (USD)

COMMON STOCK | Software - Application | OTC Pink

Last Closing

USD 0.0007

Change

0.00 (0.00)%

Market Cap

USD 0.02B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Zicix Corp provides medical diagnostic services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-22 )

Largest Industry Peers for Software - Application

Symbol Name Price(Change) Market Cap
SAPGF SAP SE

-1.50 (-0.60%)

USD 298.45B
CNSWF Constellation Software Inc

+8.66 (+0.28%)

USD 69.48B
WTCHF WiseTech Global Limited

N/A

USD 27.59B
DIDIY Didi Global Inc ADR

+0.01 (+0.21%)

USD 22.56B
XROLF Xero Limited

N/A

USD 17.37B
SGGEF The Sage Group plc

-0.05 (-0.31%)

USD 16.99B
NEMKY Nemetschek SE

N/A

USD 12.51B
LMGIF Lumine Group Inc.

N/A

USD 8.29B
TMSNY Temenos Group AG ADR

-0.74 (-1.04%)

USD 5.42B
FNOXF Fortnox AB (publ)

N/A

USD 4.15B

ETFs Containing ZICX

ZMU:CA BMO Mid-Term US IG Corpor.. 100.14 % 0.27 %

-0.05 (-0.36%)

CAD 2.99B
ETP:CA First Trust Global Risk M.. 4.04 % 0.98 %

+0.07 (+-0.36%)

CAD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Software - Application) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -22.22% 46% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.22% 46% F 37% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain -93.00% 38% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -93.00% 38% F 18% F
Average Annual (5 Year Horizon)  
Capital Gain -34.68% 10% F 5% F
Dividend Return -34.68% 10% F 5% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 45.74% 71% C- 55% F
Risk Adjusted Return -75.82% 10% F 8% B-
Market Capitalization 0.02B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative earnings

The company had negative total earnings in the most recent four quarters.